Literature DB >> 9523052

Cortical electrophysiology in migraine and possible pathogenetic implications.

J Schoenen1.   

Abstract

According to recent evoked potential studies a fundamental, probably protective, feature of cortical information processing, i.e., response habituation during stimulus repetition, is abnormal in migraine between attacks. The deficient habituation is found for different sensory modalities and experimental paradigms: pattern-reversal visual evoked potentials (same stimulus at a constant intensity), cortical auditory evoked potentials (same stimulus at increasing intensities), and auditory event-related potential obtained in a passive "oddball" paradigm (novel stimulus). The abnormal information processing is an interictal cortical dysfunction most likely due to inadequate control by the so-called "state-setting, chemically-addressed pathways" originating in the brain stem, in particular by the serotonergic pathway, leading to a low preactivation level of sensory cortices. We propose that it may play a pivotal role in migraine pathogenesis in conjunction with the reported decrease of brain mitochondrial energy reserve, by favouring a rupture of metabolic homeostasis and biochemical shifts capable of activating the trigeminovascular system and, thus, of producing a migraine attack. We postulate that both the deficient habituation in information processing and the deranged oxygen metabolism may have behavioral correlates. Which of these abnormalities are inherited, acquired, or both remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523052

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  11 in total

1.  [Altered cerebral excitability and spreading depression. Causes for the comorbidity of epilepsy and migraine?].

Authors:  T Leniger; H C Diener; A Hufnagel
Journal:  Nervenarzt       Date:  2003-06-18       Impact factor: 1.214

2.  (1)H-MRS of brain metabolites in migraine without aura: absolute quantification using the phantom replacement technique.

Authors:  Harmen Reyngoudt; Yves De Deene; Benedicte Descamps; Koen Paemeleire; Eric Achten
Journal:  MAGMA       Date:  2010-08-13       Impact factor: 2.310

Review 3.  Nonpharmacologic treatment of migraine.

Authors:  Peter S Sándor; Judit Afra
Journal:  Curr Pain Headache Rep       Date:  2005-06

Review 4.  What's in a name? tension-type headache versus migraine.

Authors:  J F Rothrock
Journal:  Curr Pain Headache Rep       Date:  2001-10

5.  Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional (1)H-MRS study.

Authors:  Harmen Reyngoudt; Koen Paemeleire; Anneloor Dierickx; Benedicte Descamps; Pieter Vandemaele; Yves De Deene; Eric Achten
Journal:  J Headache Pain       Date:  2011-02-08       Impact factor: 7.277

Review 6.  Cognitive processing in cluster headache.

Authors:  Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2005-04

Review 7.  Cortical spreading depression as a site of origin for migraine: Role of CGRP.

Authors:  Liesl N Close; Sajedeh Eftekhari; Minyan Wang; Andrew C Charles; Andrew F Russo
Journal:  Cephalalgia       Date:  2018-04-25       Impact factor: 6.292

8.  Bayesian Modeling of the Dynamics of Phase Modulations and their Application to Auditory Event Related Potentials at Different Loudness Scales.

Authors:  Zeinab Mortezapouraghdam; Robert C Wilson; Lars Schwabe; Daniel J Strauss
Journal:  Front Comput Neurosci       Date:  2016-01-28       Impact factor: 2.380

9.  Performances in cerebellar and neuromuscular transmission tests are correlated in migraine with aura.

Authors:  Anna Ambrosini; Peter S Sándor; Victor De Pasqua; Francesco Pierelli; Jean Schoenen
Journal:  J Headache Pain       Date:  2008-02-05       Impact factor: 7.277

10.  Interictal neurocognitive processing of visual stimuli in migraine: evidence from event-related potentials.

Authors:  Marla J S Mickleborough; Christine M Chapman; Andreea Simina Toma; Jeremy H M Chan; Grace Truong; Todd C Handy
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.